Results 211 to 220 of about 18,244,857 (290)

Carbon Market Price Forecasting Using a Bidirectional Temporal Convolution Exogenous-Enhanced Time-Series Model. [PDF]

Entropy (Basel)
Tang X, Tang M, Li N, Zhang S.
europepmc   +1 more source

Immune Complexes Shape the Pathogenicity of Autoantibodies in Systemic Autoimmune Diseases: Insights From an FcγRIIIA‐Reporter Assay

Arthritis &Rheumatology, EarlyView.
Objective Immune complexes (ICs), formed by autoantigen and autoantibody, play a pathogenic role in systemic autoimmune diseases through stimulation of Fcγ receptors (FcγR). However, studies investigating bioactivity of circulating ICs across various diseases remain limited.
Koji Suzuki, Masaru Takeshita, Yuki Imai, Hiroyuki Fukui, Kazunori Furuhashi, Kotaro Matsumoto, Jun Kikuchi, Keiko Yoshimoto, Yuko Kaneko   +8 more
wiley   +1 more source

Design and evaluation of bayesian optimized hybrid deep learning model for forecasting crop yields using climate dynamics. [PDF]

Sci Rep
Mushtaq N, Hashem AF, Irfan M, Mohamud LA.   +3 more
europepmc   +1 more source

Principal Component‐Based Classification of Blazar Candidates of Uncertain Type in the 4FGL/LAT

Astronomische Nachrichten, EarlyView.
ABSTRACT We adopted principal component analysis (PCA), linear discriminant analysis (LDA), and support vector machines (SVM), to study classification for a sample of 2708 Fermi blazars: 1142 BL Lac objects (BLLs), 759 flat spectrum radio quasars (FSRQs), and 807 blazar candidates of uncertain type (BCUs).
Wen‐Xin Yang, Guo‐Hai Chen, Jing‐Tian Zhu, Hong‐Guang Wang, Denis Bastieri, Xu‐Hong Ye, Jing‐Chao Liang, De‐Xiang Wu, Jiang‐He Yang, Anton A. Strigachev, Rumen S. Bachev, Jun‐Jie Feng, Yi Liu, Jun‐Hui Fan   +13 more
wiley   +1 more source

Probabilistic Forecasting and Information-Theoretic Analysis of Multivariate fMRI Dynamics. [PDF]

Entropy (Basel)
Bayer A, Zhang Z, Ipek AE, Khavari R, Aazhang B.   +4 more
europepmc   +1 more source

Adaptive imatinib regimens can mitigate cumulative toxicity while sustaining hemodynamic benefit: A model‐based simulation of the positioning imatinib for pulmonary arterial hypertension trial

British Journal of Clinical Pharmacology, EarlyView.
ABSTRACT Aims Imatinib improves hemodynamics in pulmonary arterial hypertension (PAH), but dose‐dependent toxicity has limited its clinical development. We aimed to quantify the dose–efficacy–toxicity relationship and evaluate alternative dosing strategies using data from the PIPAH trial.
Medhat M. Said, Robert B. de Mooij, Dian Jiao, Reitze J. Ovelgonne, Rami Biram, Juan Delgado‐SanMartin, Alexander M. K. Rothman, Sofia S. Villar, Andreas A. Roussakis, Jurjan Aman, Ron A. A. Mathôt, Eleonora L. Swart, Martin R. Wilkins, Imke H. Bartelink   +13 more
wiley   +1 more source

Adaptive weighted dynamic time warping clustering with a deep codec model for accurate photovoltaic power prediction. [PDF]

Sci Rep
Xin Z, Zheng G, Chi W, Lu J, Hao L.
europepmc   +1 more source

How curriculum modifications shape educational pathways: Evidence from linked administrative data in Switzerland

British Educational Research Journal, EarlyView.
Abstract The increasing heterogeneity of learning needs and preconditions in inclusive mainstream classrooms entails that not all learners are equally able to meet the regular learning objectives. In response, various integrative measures have been implemented to tailor instruction to students' individual needs.
Robin Benz, Caroline Sahli Lozano, Esperanza Marx   +2 more
wiley   +1 more source

Comparative analysis of CNN-LSTM and CNN-BiLSTM hybrid deep learning models for solar radiation prediction. [PDF]

Sci Rep
Raghav YY, Kumari P, Katta PK, Kathuria S, Mudgal M, Prabhakar M, Yusuf M.   +6 more
europepmc   +1 more source

Cell and Gene Therapies Manufacturing Challenges and Integrated Good Manufacturing Practices Solutions: A Lifecycle Perspective

Biotechnology and Bioengineering, EarlyView.
Lifecycle perspective on cell and gene therapy manufacturing challenges and enabling GMP solutions. ABSTRACT Cell and gene therapies (CGTs) are revolutionizing modern medicine; however, making these advanced medicines scalable and readily available to commercial manufacturers worldwide is a major challenge. The number of approved CGT products continues
Rajath Samaga, Udisha Singh, Sachin Dattram Pawar   +2 more
wiley   +1 more source